Sever Clint's Form 4/A amendment
AmendedCue Health Inc. (HLTH) · filed Sep 15, 2022
- Accession no.
- 0001628945-22-000124
- Filed
- Sep 15, 2022
- Trade date
- Aug 4, 2022
- Filing delay
- 42 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
- Original filed
- Aug 4, 2022
This filing lists 1 derivative transaction. It carries over 8 transactions from the original filing that it did not restate. Open-market sales total $283.5K. It was filed 42 days after the trade.
This amendment restates part of 0001628945-22-000087 (filed Aug 4, 2022). The transactions it did not restate still count and are listed below.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sever ClintCIK 0001868945 | Officer (Chief Product Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
This filing has no transactions of this kind.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 4, 2022 | Common Stock | MOption exerciseDisposed | −26,664 | $0.00 | $0 | 720,016 | Direct |
Carried over from the original filing
This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.
From 0001628945-22-000087 (filed Aug 4, 2022).
Non-derivative securities (Table I)
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2022 | Common Stock | MOption exerciseAcquired | +26,664 | $0.20 | +$5,332.8 | 4,012,852 | Direct | |
| Aug 2, 2022 | Common Stock | SSaleDisposed | −26,664 | $3.40F2 | −$90,630.94 | 3,986,188 | Direct | |
| Aug 3, 2022 | Common Stock | MOption exerciseAcquired | +26,664 | $0.20 | +$5,332.8 | 4,012,852 | Direct | |
| Aug 3, 2022 | Common Stock | SSaleDisposed | −26,664 | $3.58F3 | −$95,563.78 | 3,986,188 | Direct | |
| Aug 4, 2022 | Common Stock | MOption exerciseAcquired | +26,664 | $0.20 | +$5,332.8 | 4,012,852 | Direct | |
| Aug 4, 2022 | Common Stock | SSaleDisposed | −26,664 | $3.65F4 | −$97,270.27 | 3,986,188 | Direct |
Derivative securities (Table II)
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 2, 2022 | Common Stock | MOption exerciseDisposed | −26,664 | $0.00 | $0 | 773,344 | Direct | |
| Aug 3, 2022 | Common Stock | MOption exerciseDisposed | −26,664 | $0.00 | $0 | 746,680 | Direct |
Footnotes on the original
The footnotes that the prices of these transactions refer to on the original filing.
- F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.25 to $3.46, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4) to this Form 4.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.50 to $3.67, inclusive.
Referenced by the price of 1 transaction in Table I.
- F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.57 to $3.76, inclusive.
Referenced by the price of 1 transaction in Table I.
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Shares subject to the option are fully vested and immediately exercisable.
Remarks
This amendment on Form 4 is filed to correct an overstatement of 240,000 shares in Columns 5, 7 and 9 of Table II in a Form 4 filed on August 4, 2022. The overstatement of shares appears in Column 9 of two subsequent Forms 4 filed on August 18, 2022 and September 1, 2022.